Ex Parte YAMANA et al - Page 8



          Appeal No. 2000-0482                                                        
          Application 08/569,256                                                      


          of these arguments is persuasive.  Claim 1 uses the term                    
          “comprising” and, therefore, does not exclude additional                    
          unrecited elements such as mineral fillers.  Moleculon Research             
          Corp. v. CBS, Inc., 793 F.2d 1261, 1271, 229 USPQ 805, 812 (Fed.            
          Cir. 1986), cert. denied, 479 U.S. 1030 (1987).  The claims are             
          also not limited to the use of PTFE strictly as a release agent.            
          See In re Mraz, 455 F.2d 1069, 1072-73, 173 USPQ 25, 27-28 (CCPA            
          1972).  Accordingly, we find that the examiner has established a            
          prima facie case of obviousness.                                            
                    A prima facie case of obviousness may be rebutted if              
          the appellant (1) establishes unexpected properties in the                  
          claimed composition or (2) shows that the art, in any material              
          respect, teaches away from the claimed invention.  In re                    
          Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974).               
          Appellants rely on the Yamaguchi Declaration under 37 CFR § 1.132           
          (Paper No. 16, received January 25, 1999) as providing evidence             
          of unexpected results.  The examiner found that appellants’                 
          evidence was not sufficient to demonstrate a synergistic effect             
          of the claimed composition since appellants failed to make a                
          showing of unexpected results commensurate in scope with the                
          claims.  Examiner’s Answer, page 5.  We agree.  See In re Dill,             
                                          8                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007